Dan will take over from Ingela Hofverberg, who has been interim Group CEO and will now revert full-time to her role as head of the Atlas Antibodies business unit.

“We are thrilled to welcome Dan to Atlas Antibodies Group,” says Åsa Riisberg, Chairman of the Board. “His extensive industry knowledge, combined with a strong track record of driving growth through customer-centric strategies, makes him an excellent fit to lead the company into its next phase of development.” 

Dan Pitulia

Dan brings experience from the life science and healthcare industries, having held leadership roles at e.g. QleanAir, Carmel Pharma and Mölnlycke. Most recently, he served as CEO of Coala Life. 

“I am excited to join Atlas Antibodies Group at such a pivotal moment,” says Dan Pitulia. “I look forward to working alongside the talented team here to continue delivering exceptional products and services to our customers, as well as exploring new avenues for growth and innovation.”